Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4458881
Max Phase: Preclinical
Molecular Formula: C65H127N11O11S
Molecular Weight: 1270.86
Molecule Type: Unknown
Associated Items:
ID: ALA4458881
Max Phase: Preclinical
Molecular Formula: C65H127N11O11S
Molecular Weight: 1270.86
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCOC(=O)NCCSC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
Standard InChI: InChI=1S/C65H127N11O11S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-37-48-87-65(86)70-47-49-88-51-57(71-58(78)42-28-26-24-22-20-18-16-14-12-10-8-6-4-2)63(83)76-56(50-77)62(82)74-53(39-30-34-44-67)60(80)72-52(38-29-33-43-66)59(79)73-54(40-31-35-45-68)61(81)75-55(64(84)85)41-32-36-46-69/h52-57,77H,3-51,66-69H2,1-2H3,(H,70,86)(H,71,78)(H,72,80)(H,73,79)(H,74,82)(H,75,81)(H,76,83)(H,84,85)/t52-,53-,54-,55-,56+,57-/m0/s1
Standard InChI Key: IVPCAGDUNGUTBP-ZRBLSXMTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1270.86 | Molecular Weight (Monoisotopic): 1269.9437 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Du X, Qian J, Wang Y, Zhang M, Chu Y, Li Y.. (2019) Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam3CSK4., 27 (13): [PMID:31101493] [10.1016/j.bmc.2019.05.005] |
Source(1):